Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.37, read 2026-11-05
Ethical passes the values gate
Price49.31 USD
Fair value50.00
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup49.31+0.0% to today ✓Accumulation gives way to Markup first Markup read since October
2026-10-28Read Accumulation50.75-2.8% to today Markup gives way to Accumulation after an 18% rise in 4 weeks
2026-10-02Read Markup43.00+14.7% to today ✓Accumulation gives way to Markup after a 10% rise in 3 weeks
2026-09-11Read Accumulation39.12+26.0% to today ✓Distribution gives way to Accumulation after a 9% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Roblox Corp holds its Markup at $49.31. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-11-04
Phase
Markup
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$49.31
Valuation
N/A trailing · -35.68 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.53
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
18.86%
Below 33%
Interest-bearing debt is just 18.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
19.36%
Below 33%
Cash held in interest-bearing accounts and securities is 19.4% of assets, under the one-third limit.
Pass
Receivables
22.04%
Below 49%
Money owed to the company is 22.0% of assets, under the 49% limit.
Pass
Revenue purity
4.12%
Below 5%
Only 4.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Roblox clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 19%, inside the ~33% line, and interest is about 4% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RBLX's ethical verdict changes
Today RBLX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades at roughly a 1% discount to our $50.00 fair value, narrow competitive moat, 15.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 1.4% discount to the base estimate.
Where our models see it going: fair-value estimate $50.00, with a range of $33.00 to $65.00, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Kids build worlds while Roblox burns cash
Teenagers log on to create and trade inside virtual worlds that feel more real than the school run. Roblox has built a platform millions treat as their third place, yet the numbers still show heavy losses. Revenue is rising 39 percent, but margins sit at minus 21 percent and return on equity is deeply negative.
We pass despite the 20 percent gap to fair value and a clean ethical screen. Forward earnings sit at a negative 40 times multiple, the moat remains narrow, and growth alone does not turn a loss-making model into a durable business. Analyst targets cluster at the same 62 dollars the model already prices, offering no extra edge.
The real risk is simple. Strong user numbers can mask how quickly spending on servers and creators eats any profit. One slowdown in engagement would widen losses fast and leave the narrow competitive edge exposed. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
RBLX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup · changed$49.31-7.5%Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter.
2026-10-29Accumulation$53.28+5.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup$50.75+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$50.75+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$50.75+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$50.75+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$50.75+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup$50.75-0.7%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$51.13+18.9%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (32 analysts) rates it buy, with a mean price target of $65. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
